Endothelin-1 in peripheral arterial disease: a potential role in muscle damage

Area of Science:

• Vascular biology
• Cardiovascular research
• Atherosclerosis studies

Background:

• Endothelin-1 (ET-1) is implicated in endothelial dysfunction and atherosclerosis.
• Research has primarily focused on cardiac disease, leaving the role of ET-1 in peripheral arterial disease (PAD) less understood.
• ET-1's impact extends beyond atherosclerotic lesions to affect microvessels and ischemic muscle viability.

Purpose of the Study:

• To review the evidence for endothelin-1's role in peripheral arterial disease (PAD).
• To highlight ET-1's adverse effects on lower limb arteries, muscle microvessels, and ischemic muscle viability.
• To underscore the potential of endothelin antagonists in PAD treatment.

Main Methods:

• Literature review of studies on endothelin-1 and peripheral arterial disease.
• Synthesis of findings regarding ET-1's impact on atherosclerotic lesions in lower limb arteries.
• Analysis of evidence concerning ET-1's effects on muscle microvasculature and tissue viability.

Main Results:

• Growing evidence links endothelin-1 to endothelial dysfunction and atherosclerosis.
• ET-1 contributes to the development and progression of atherosclerotic lesions in lower limb arteries.
• ET-1 negatively impacts muscle microvessels and the viability of ischemic muscle.

Conclusions:

• Endothelin-1 plays a significant detrimental role in peripheral arterial disease.
• Targeting ET-1 with antagonists presents a potential adjunctive therapeutic strategy for PAD.
• Further research into ET-1's mechanisms in PAD could lead to improved treatment outcomes.